
Gene Therapy Manufacturing
Our gene therapy services, delivered through Forge Biologics, support programs from concept to commercial with high-yield AAV manufacturing, a world-class cGMP facility, proprietary technologies, and deep gene therapy expertise.
Accelerate with the FUEL™ Platform
Forge’s FUEL™ platform provides an established foundation for AAV manufacturing, combining proprietary technologies and proven processes with product-specific optimization to improve productivity and recovery while maintaining product quality.

Proprietary Technologies
Our gene therapy proprietary technologies, including the Ignition™ Cell Line, pEMBR™ 2.0 Ad Helper Plasmid, and Modified Rep Caps, support more efficient AAV manufacturing.
Product-Specific Optimizations
We’ve mapped 50+ upstream and downstream studies to help optimize yield, purity, and efficiency
Proven Processes
With over 600 manufacturing batches completed to date across dozens of indications and every serotype, including novel, our platform manufacturing processes are well established and backed by extensive real-world experience
Proven Experience, Trusted Technology
These numbers reflect more than experience. They represent the trusted partnerships built by the clients who choose us.
60+
Clients Supported Across All Stages
97%
Of Clients Use Our Technologies
600+
Batches Manufactured
35+
Indications That We Expertly Support
A Specialized Partner
As part of Aji Bio-Pharma, Forge brings a dedicated gene therapy manufacturing service built on specialized expertise, purpose-built infrastructure, and proprietary technologies to a network of specialized CDMOs and enabling technologies.
Backed by Global Scale
Forge’s dedicated gene therapy expertise is backed by Aji Bio-Pharma’s global resources and commitment to rigorous quality, operational excellence, sustainability, and a century-long legacy of scientific innovation.

Learn More at Forge Biologics
Let’s talk about how we can scale your AAV research today.